Healthcare provider profile · identity verified

Francis Alcedo, MD

Internal Medicine · TRUMBULL, CT · NPI 1225091713

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	664	211
Atorvastatin Calcium	Atorvastatin Calcium	646	195
Levothyroxine Sodium	Levothyroxine Sodium	324	97
Metformin Hcl	Metformin Hcl	311	88
Lisinopril	Lisinopril	297	91
Albuterol Sulfate Hfa	Albuterol Sulfate	195	45
Hydrochlorothiazide	Hydrochlorothiazide	195	64
Omeprazole	Omeprazole	187	48
Metoprolol Succinate	Metoprolol Succinate	178	60
Rosuvastatin Calcium	Rosuvastatin Calcium	160	61
Losartan Potassium	Losartan Potassium	146	47
Montelukast Sodium	Montelukast Sodium	132	35
Pantoprazole Sodium	Pantoprazole Sodium	131	38
Tramadol Hcl	Tramadol Hcl	127	32
Allopurinol	Allopurinol	121	30
Furosemide	Furosemide	118	41
Tamsulosin Hcl	Tamsulosin Hcl	116	32
Escitalopram Oxalate	Escitalopram Oxalate	113	28
Simvastatin	Simvastatin	110	35
Valsartan	Valsartan	103	34
Fluticasone Propionate	Fluticasone Propionate	97	29
Alprazolam	Alprazolam	92	33
Trazodone Hcl	Trazodone Hcl	91	26
Zolpidem Tartrate	Zolpidem Tartrate	90	20
Eliquis	Apixaban	89	24
Glimepiride	Glimepiride	88	32
Januvia	Sitagliptin Phosphate	88	29
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	88	23
Finasteride	Finasteride	85	21
Ezetimibe	Ezetimibe	78	25
Pravastatin Sodium	Pravastatin Sodium	78	29
Sertraline Hcl	Sertraline Hcl	70	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	suppressed
Atenolol	Atenolol	67	22
Mirtazapine	Mirtazapine	65	14
Gabapentin	Gabapentin	62	21
Naproxen	Naproxen	61	28
Clopidogrel	Clopidogrel Bisulfate	57	16
Duloxetine Hcl	Duloxetine Hcl	57	19
Tradjenta	Linagliptin	57	17
Jardiance	Empagliflozin	55	16
Metoprolol Tartrate	Metoprolol Tartrate	54	18
Famotidine	Famotidine	53	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	51	28
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	48	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	13
Meclizine Hcl	Meclizine Hcl	47	18
Potassium Chloride	Potassium Chloride	47	14
Lorazepam	Lorazepam	46	13
Breo Ellipta	Fluticasone/Vilanterol	45	suppressed
Carvedilol	Carvedilol	45	17
Olmesartan Medoxomil	Olmesartan Medoxomil	43	15
Ozempic	Semaglutide	43	suppressed
Ventolin Hfa	Albuterol Sulfate	43	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	15
Citalopram Hbr	Citalopram Hydrobromide	39	17
Lovastatin	Lovastatin	39	12
Synthroid	Levothyroxine Sodium	38	suppressed
Alendronate Sodium	Alendronate Sodium	35	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Pregabalin	Pregabalin	34	suppressed
Benazepril Hcl	Benazepril Hcl	33	12
Colchicine	Colchicine	33	suppressed
Methylprednisolone	Methylprednisolone	33	30
Triamcinolone Acetonide	Triamcinolone Acetonide	33	20
Nebivolol Hcl	Nebivolol Hcl	32	11
Chlorthalidone	Chlorthalidone	28	suppressed
Clonazepam	Clonazepam	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	19
Labetalol Hcl	Labetalol Hcl	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	11
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	13
Azithromycin	Azithromycin	23	20
Farxiga	Dapagliflozin Propanediol	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Meloxicam	Meloxicam	20	12
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Levemir Flexpen	Insulin Detemir	19	suppressed
Single Use Swab	Alcohol Antiseptic Pads	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	14
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	16
Verapamil Er	Verapamil Hcl	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Diazepam	Diazepam	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Budesonide	Budesonide	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error